Panacea Venture

CASI focus on building a pipeline through mutually beneficial business development transactions.

Actym Therapeutics is a biotech company that focuses on the discovery and development of novel immuno-oncology therapies to treat cancer.

New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.

HC Bioscience is an innovator and pioneer of protein editing using context agnostic engineered tRNA.

Domain Therapeutics develops small molecules targeting G-coupled protein receptors.

The future of infectious disease diagnostics starts at Day Zero.

Inmagene is a clinical-stage biotech company developing innovative and differentiated therapies for immunological and inflammatory diseases.

Chime Biologics is a biopharmaceutical development and manufacturing company.

Zhaoke Ophthalmology Pharmaceutical is a Pharmaceutical platform.

XW Laboratories develops a portfolio of internally discovered product candidates for the potential treatment of neurological disorders.